# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2187115 | A | Free drug concentration in C57BL/6 mouse brain at 300 umol/kg, po at 1.5 hrs | Mus musculus | 4 | organism-based format | Scientific Literature | ||
2. | ALA2187121 | A | Free drug concentration in C57BL/6 mouse plasma at 300 umol/kg, po at 1.5 hrs | Mus musculus | 4 | organism-based format | Scientific Literature | ||
3. | ALA2187536 | F | Antialzheimer activity in C57BL/6 mouse assessed as reduction in sAPPbeta level in brain at 300 umol/kg, po | Mus musculus | 4 | organism-based format | Scientific Literature | ||
4. | ALA2187542 | F | Antialzheimer activity in C57BL/6 mouse assessed as reduction in amyloid beta 42 level in brain at 300 umol/kg, po | Mus musculus | 4 | organism-based format | Scientific Literature | ||
5. | ALA2187550 | A | Fraction unbound in C57BL/6 mouse brain at 300 umol/kg, po | Mus musculus | 4 | organism-based format | Scientific Literature | ||
6. | ALA2187556 | A | Fraction unbound in C57BL/6 mouse plasma at 300 umol/kg, po | Mus musculus | 4 | organism-based format | Scientific Literature | ||
7. | ALA2187562 | F | Antialzheimer activity in C57BL/6 mouse assessed as reduction in amyloid beta 40 level in brain at 300 umol/kg, po at 1.5 hrs by ELISA relative to control | Mus musculus | 4 | organism-based format | Scientific Literature | ||
8. | ALA2187563 | B | Inhibition of BACE1-mediated amyloid beta 40 release in C57/BL6 mouse primary cortical neurons after overnight incubation by ELISA | Mus musculus | 9 | single protein format | Scientific Literature | ||
9. | ALA2182698 | B | Inhibition of human recombinant BACE2 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by TR-FRET assay | Homo sapiens | 9 | single protein format | Scientific Literature | ||
10. | ALA2182702 | P | Lipophilicity, log D of the compound by RP-HPLC analysis | 27 | small-molecule physicochemical format | Scientific Literature | |||
11. | ALA2182704 | P | Dissociation constant, pKa of the compound by pressure-assisted capillary electrophoretic analysis | 27 | small-molecule physicochemical format | Scientific Literature | |||
12. | ALA2182705 | A | Intrinsic clearance in rat hepatocytes assessed per 10'6 cells | Rattus norvegicus | 27 | cell-based format | Scientific Literature | ||
13. | ALA2182706 | B | Inhibition of human ERG expressed in CHO cells by IonWorks assay | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
14. | ALA2182707 | A | Efflux ratio of apparent permeability from basal to apical to apical to basal side of human Caco2 cells at 10 uM after 60 mins by LC/MS analysis | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
15. | ALA2182708 | A | Apparent permeability from apical to basal side of human Caco2 cells at 10 uM after 60 mins by LC/MS analysis | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
16. | ALA2183078 | B | Inhibition of BACE1 in human SH-SY5Y cells assessed as inhibition of sAPPbeta release after 16 hrs by immunoassay | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
17. | ALA2183079 | B | Inhibition of human recombinant BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by TR-FRET assay | Homo sapiens | 27 | single protein format | Scientific Literature | ||
18. | ALA3531478 | A | Activity of human recombinant CYP3A4 expressed in insect BTI-TN-5B1-4 cell microsomes assessed as enzyme-mediated drug metabolism measured as 2-(3-amino-4-fluoro-1-(pyridin-4-yl)-1H-isoindol-1-yl)-4-(pyrimidin-5-yl)phenol level at 2 uM after 30 mins | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
19. | ALA3531575 | A | Drug metabolism in Sprague-Dawley rat liver microsomes assessed as GSH conjugate formation at 10 uM by LC-MS analysis | Rattus norvegicus | 1 | assay format | Scientific Literature | ||
20. | ALA3531576 | A | Activity of human recombinant CYP3A4 expressed in insect BTI-TN-5B1-4 cell microsomes assessed as enzyme-mediated drug metabolism measured as 4-(3-amino-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-1-yl)pyridine 1-oxide level at 2 uM after 30 mins | Homo sapiens | 1 | cell-based format | Scientific Literature |